Sell-Side Sees Upside & Positive Growth in HealthEquity, Inc. (NASDAQ:HQY)

HealthEquity, Inc. (NASDAQ:HQY) has been recommended as a long term growth stock according to analysts at Beta Research.  With their stock price currently trading around $88.69, the firm has proven a solid track record of growth over the past few years.  Investors might consider the stock as a long term growth candidate as the firm has yielded 57.00% earnings per share growth over the past 5 years and 37.90% revenue growth over that same time frame. 

One of the staple principles for investing is buy low and sell high. While this may sound obvious, many investors end up doing just the opposite. When dealing with the stock market, investors often have to be careful not to let their irrational side take over when making decisions. Investors may get caught up in the flurry when stocks are skyrocketing. The temptation to get on board and be part of the ride can lead to some ill-planned moves. Focusing on near-term movements might be included in the game plan for some, but for others, this may be distracting from the bigger picture and long-term plan. Stocks that become widely publicized and popular in the media may not be the right addition to the individual investor’s portfolio. Conducting the due diligence on any position can help the investor make sure that they are getting in at a good time and price.

Long-term growth (LTG) is an investing strategy where a stock will (hopefully) grow in value for a relatively long period of time.  Long-term growth should be considered to be a relative term, due to different styles and goals of investors, but the endgame is the same. 

Recent Performance

Let’s take a look at how the stock has been performing recently.  Over the past twelve months, HealthEquity, Inc. (NASDAQ:HQY)’s stock was 90.08%.  Over the last week of the month, it was 14.62%, -5.86% over the last quarter, and  16.15% for the past six months. 

Over the past 50 days, HealthEquity, Inc.’s stock is -12.69% off of the high and 20.81% removed from the low.  Their 52-Week High and Low are as follows: -12.69% (High), 106.64%, (Low). 

Analyst Recommendation

Despite the past success, investors want to know where the stock is headed from here.  Analysts covering the shares have a consensus short-term price target of $102.25 on the equity.   Analysts have a consensus recommendation of 1.90 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.  

Investing in the stock market will always come with ups and downs. There are so many different factors that can have an impact on the day to day movements of stock prices. Finding the correct investing strategy may take some time. Many investors may have the tendency to become impatient when the portfolio is not performing up to snuff. Sometimes an original plan may be solid, but it needs some time to start to work itself out. Staying on the right track can be much easier said than done. There are always forces leading the investor to question their holdings. Giving up on a strategy too early can result in a lot of second guessing. There may be a time when the plan needs to be modified to adapt with changing market environments, but pulling the cord based on some early trouble may not be the best solution.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.